AAAAAA
Results:
1-15
|
Results: 15
Authors:
Giantonio, BJ
Hochster, H
Blum, R
Wiernik, PH
Hudes, GR
Kirkwood, J
Trump, D
Oken, MM
Citation: Bj. Giantonio et al., Toxicity and response evaluation of the interferon inducer poly ICLC administered at low dose in advanced renal carcinoma and relapsed or refractory lymphoma: A report of two clinical trials of the Eastern Cooperative Oncology Group, INV NEW DR, 19(1), 2001, pp. 89-92
Authors:
Ng, B
Kramer, E
Liebes, L
Wasserheit, C
Hochster, H
Blank, E
Ceriani, R
Furmanski, P
Citation: B. Ng et al., Radiosensitization of tumor-targeted radioimmunotherapy with prolonged topotecan infusion in human breast cancer xenografts, CANCER RES, 61(7), 2001, pp. 2996-3001
Authors:
Liebes, L
Conaway, CC
Hochster, H
Mendoza, S
Hecht, SS
Crowell, J
Chung, FL
Citation: L. Liebes et al., High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: Application to studies with 2-phenethyl isothiocyanate, ANALYT BIOC, 291(2), 2001, pp. 279-289
Authors:
Schilsky, RL
Bukowski, R
Burris, H
Hochster, H
O'Rourke, M
Wall, JG
Mani, S
Bonny, T
Levin, J
Hohneker, J
Citation: Rl. Schilsky et al., A multicenter phase II study of a five-day regimen of oral 5-fluorouracil plus eniluracil with or without leucovorin in patients with metastatic colorectal cancer, ANN ONCOL, 11(4), 2000, pp. 415-420
Authors:
Mani, S
Hochster, H
Beck, T
Chevlen, EM
O'Rourke, MA
Weaver, CH
Bell, WN
White, R
McGuirt, C
Levin, J
Hohneker, J
Schilsky, RL
Lokich, J
Citation: S. Mani et al., Multicenter phase II study to evaluate a 28-day regimen of oral fluorouracil plus eniluracil in the treatment of patients with previously untreated metastatic colorectal cancer, J CL ONCOL, 18(15), 2000, pp. 2894-2901
Authors:
Cooper, JS
Lee, H
Torrey, M
Hochster, H
Citation: Js. Cooper et al., Improved outcome secondary to concurrent chemoradiotherapy for advanced carcinoma of the nasopharynx: Preliminary corroboration of the intergroup experience, INT J RAD O, 47(4), 2000, pp. 861-866
Authors:
Rosenthal, MA
Gruber, ML
Glass, J
Nirenberg, A
Finlay, J
Hochster, H
Muggia, FM
Citation: Ma. Rosenthal et al., Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme, J NEURO-ONC, 47(1), 2000, pp. 59-63
Authors:
Kiremidjian-Schumacher, L
Roy, M
Glickman, R
Schneider, K
Rothstein, S
Cooper, J
Hochster, H
Kim, M
Newman, R
Citation: L. Kiremidjian-schumacher et al., Selenium and immunocompetence in patients with head and neck cancer, BIOL TR EL, 73(2), 2000, pp. 97-111
Authors:
Wadler, S
Schwartz, EL
Anderson, P
Runowicz, CD
Chuang, L
Del Priore, G
Hochster, H
Goldberg, G
Fields, A
Loewen, G
Haynes, H
Citation: S. Wadler et al., Preliminary phase II clinical and pharmacokinetic study of 9-cis retinoic acid in advanced cervical cancer, CA J SCI AM, 5(3), 1999, pp. 165-170
Authors:
Hochster, H
Strawderman, MH
Harris, JE
Atkins, MB
Oken, M
Skeel, RT
Jubelirer, SJ
Parkinson, D
Citation: H. Hochster et al., Conventional dose melphalan is inactive in metastatic melanoma: results ofan Eastern Cooperative Oncology Group Study (E1687), ANTI-CANC D, 10(2), 1999, pp. 245-248
Authors:
Vogel, C
O'Rourke, M
Winer, E
Hochster, H
Chang, A
Adamkiewicz, B
White, R
McGuirt, C
Citation: C. Vogel et al., Vinorelbine as first-line chemotherapy for advanced breast cancer in women60 years of age or older, ANN ONCOL, 10(4), 1999, pp. 397-402
Authors:
Hochster, H
Wadler, S
Runowicz, C
Liebes, L
Cohen, H
Wallach, R
Sorich, J
Taubes, B
Speyer, J
Citation: H. Hochster et al., Activity and pharmacodynamics of 21-day topotecan infusion in patients with ovarian cancer previously treated with platinum-based chemotherapy, J CL ONCOL, 17(8), 1999, pp. 2553-2561
Authors:
Kucuk, O
Pandya, KJ
Skeel, RT
Hochster, H
Abeloff, MD
Citation: O. Kucuk et al., Phase II study of cisplatin and 5-fluorouracil in previously treated metastatic breast cancer: an Eastern Cooperative Oncology Group study (PA 185), BREAST CANC, 57(2), 1999, pp. 201-206
Authors:
Hochster, H
Speyer, JL
Mandeli, JP
Runowicz, C
Wadler, S
Berk, G
Wallach, R
Holland, JF
Citation: H. Hochster et al., A phase II double-blind randomized study of the simultaneous administration of recombinant human interleukin-6 and recombinant human granulocyte colony-stimulating factor following paclitaxel and carboplatin chemotherapy in patients with advanced epithelial ovarian cancer, GYNECOL ONC, 72(3), 1999, pp. 292-297
Authors:
Hochster, H
Oratz, R
Ettinger, DS
Borden, E
Citation: H. Hochster et al., A phase II study of Didemnin B (NSC 325319) in advanced malignant melanoma: an Eastern Cooperative Oncology Group study (PB687), INV NEW DR, 16(3), 1998, pp. 259-263
Risultati:
1-15
|